An independent two-stage DCF analysis by a frontier AI model.
HCA Healthcare's fundamental advantage lies in its unparalleled scale. As the largest non-governmental hospital operator in the US, it leverages this size to negotiate favorable reimbursement rates with commercial payers and achieve significant purchasing efficiencies. This scale allows HCA to continually reinvest in state-of-the-art facilities and technology, attracting top-tier physicians and driving patient volume.
While the hospital sector faces chronic headwinds like nursing shortages and wage inflation, HCA has consistently proven to be the 'best house in a tough neighborhood.' By aggressively expanding its higher-margin outpatient and ambulatory surgery centers, HCA is adapting to shifting care delivery models while solidifying its dominance in key, fast-growing regional markets. At current prices, the market appears to be fairly valuing HCA's reliable cash generation and competitive position.
A 5% growth rate is assumed, reflecting HCA's steady, low-to-mid single-digit revenue growth and consistent operational execution, balanced against ongoing labor cost pressures and the mature nature of the hospital industry.
An 8% discount rate is utilized. This reflects HCA's stable cash flows, dominant market position, and strong execution history, offset slightly by regulatory risks inherent in the healthcare sector.
A 2% terminal growth rate aligns with long-term macroeconomic inflation targets and the steady, demographically driven growth expected in the US healthcare market.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 1.0% | $578.58 | $482.15 | $413.27 | $361.61 | $321.43 |
| 1.5% | $642.87 | $525.98 | $445.06 | $385.72 | $340.34 |
| 2.0% | $723.23 | $578.58 | $482.15 | $413.27 | $361.61 |
| 2.5% | $826.54 | $642.87 | $525.98 | $445.06 | $385.72 |
| 3.0% | $964.30 | $723.22 | $578.58 | $482.15 | $413.27 |
■ Undervalued vs current price ■ Overvalued vs current price
A 5% rate represents a normalized expectation for a mature, large-scale healthcare operator. It accounts for steady volume growth driven by an aging population and modest pricing power, balanced against structural margin pressures from labor and supply costs.
The computed intrinsic value is very close to the current market price, indicating that the market has accurately priced in HCA's strong operational performance and future cash flow prospects. There is currently a negligible margin of safety.
The most significant risks are unexpected adverse changes to government reimbursement rates (Medicare/Medicaid) or an inability to manage persistent wage inflation, which could compress operating margins more than anticipated.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.